Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILHEP: Perioperative IV Lidocaine for Postoperative Opioid Side Effects After Open Hepatectomy
NCT07590830Phase 4Not yet recruiting
- Sponsor
- CHU Rennes
- Start
- Aug 2026
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, opioid use disorder (OUD), sponsored by CHU Rennes. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07590830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07590830.